Medical Market Report

Global Monogenetic Disorders Testing Market By Type (Carrier Testing, Diagnostic Testing, New-Born Screening, Predictive & Pre-Symptomatic Testing, Prenatal Testing, Others), By Application (Hospitals, Specialized Clinics, Ambulatory Surgical Centers), By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 135381
  • 16-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Global Monogenetic Disorders Testing Market offers in-depth analysis on market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report include the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global monogenetic disorders testing Market is segmented on the basis of Type, Application, and geography.
    The worldwide market for Global Monogenetic Disorders Testing Market is expected to grow at a CAGR of roughly x.x% over the next ten years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Monogenetic Disorders Testing Market Scope:

    By type, the market is segmented into Carrier Testing, Diagnostic Testing, New-Born Screening, Predictive & Pre-Symptomatic Testing, Prenatal Testing, and Others. By Application, the market is divided into Hospitals, Specialized Clinics, and Ambulatory Surgical Centers.
    Based on geography, market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Celera Group, Abbott, Thermo Fisher Scientific, ELITech Group, Quest, AutoGenomics, PerkinElmer, Roche, Bio-Rad, and Transgenomic.

    Key Market Segments

    Type

    Carrier Testing

    Diagnostic Testing

    New-Born Screening

    Predictive & Pre-Symptomatic Testing

    Prenatal Testing

    Others

    Application

    Hospitals

    Specialized Clinics

    Ambulatory Surgical Centers

    Key Market Players included in the report:

    Celera Group

    Abbott

    Thermo Fisher Scientific

    ELITech Group

    Quest

    AutoGenomics

    PerkinElmer

    Roche

    Bio-Rad

    Transgenomic

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis industry research (global industry trends) and Global Monogenetic Disorders Testing Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Global Monogenetic Disorders Testing Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Global Monogenetic Disorders Testing Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Monogenetic Disorders Testing Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Global Monogenetic Disorders Testing Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Global Monogenetic Disorders Testing Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Global Monogenetic Disorders Testing Market sub-markets, depending on key regions (various vital states).
    To analyze Global Monogenetic Disorders Testing Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Global Monogenetic Disorders Testing Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2012 to 2018, and also prediction to 2028.
    Primary worldwide Global Monogenetic Disorders Testing Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Global Monogenetic Disorders Testing Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Monogenetic Disorders Testing Market Overview
    

    3.1. Global Monogenetic Disorders Testing Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Manufacturer Intensity Map4. Global Monogenetic Disorders Testing Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Monogenetic Disorders Testing Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Carrier Testing
    

      4.4. Diagnostic Testing
    

      4.5. New-Born Screening
    

      4.6. Predictive & Pre-Symptomatic Testing
    

      4.7. Prenatal Testing
    

      4.8. Others5. Global Monogenetic Disorders Testing Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Monogenetic Disorders Testing Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospitals
    

      5.4. Specialized Clinics
    

      5.5. Ambulatory Surgical Centers6. Global Monogenetic Disorders Testing Market Value ((US$ Mn)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Global Monogenetic Disorders Testing Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Global Monogenetic Disorders Testing Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Global Monogenetic Disorders Testing Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia
    

      6.4. Latin America
    

        6.4.1. Latin America Global Monogenetic Disorders Testing Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Global Monogenetic Disorders Testing Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Monogenetic Disorders Testing Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Celera Group
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3. 3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Abbott
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4. 4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Thermo Fisher Scientific
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5. 5. Key Strategies and Developments  7.6. ELITech Group
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Quest
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. AutoGenomics
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. PerkinElmer
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7. 10.Roche
    

        7. 10.1. Company Overview
    
    7. 10.2. Financial Highlights
    
    7. 10.3. Product Portfolio
    
    7. 10.4. SWOT Analysis
    
    7. 10.5. Key Strategies and Developments  7. 11. Bio-Rad
    

        7. 11.1. Company Overview
    
    7. 11.2. Financial Highlights
    
    7. 11.3. Product Portfolio
    
    7. 11.4. SWOT Analysis
    
    7. 11.5. Key Strategies and Developments  7. 12. Transgenomic
    

        7. 12.1. Company Overview
    
    7. 12.2. Financial Highlights
    
    7. 12.3. Product Portfolio
    
    7. 12.4. SWOT Analysis
    
    7. 12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10.Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.